Alexion Pharmaceuticals' Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest Alexion Pharmaceuticals careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

Position Summary This position is accountable for the timely preparation of high quality, regulatory-compliant clinical document deliverables for Alexion. This position will support the medical writing (WM) activities for one or more cli...
Posted: December 12, 2018, 3:25 am
Position Summary The Senior Manager, Global Advertising and Promotional Compliance serves as the Regulatory Affairs (RA) representative on product promotion review teams. The Senior Manager has responsibility for reviewing and approving t...
Posted: December 12, 2018, 3:25 am
Position Summary and Principal Activities: The Associate Director will play a key role in the successful creation and execution of launch strategies and tactics for NMOSD - a rare, devastating, complement-mediated disorder of t...
Posted: December 12, 2018, 3:25 am
Position Summary Professionally represent Alexion in educating LAL-D disease customers and identifying patients impacted by LAL-D and ensure high levels of visibility to Alexion’s disease awareness initiatives and a high degree of customer satisfa...
Posted: December 11, 2018, 1:15 pm
Position Summary Professionally represent Alexion in the field and ensure high levels of visibility and customer satisfaction in territory. Implement the Alexion sales/marketing disease, diagnostic and branded education awareness programs. Maintai...
Posted: December 11, 2018, 1:15 pm

Viewing page 1 of 37|Next Page

  Newsfeed | Subscribe  

Estimates for 2019 have increased 20 cents in the past 60 days. Based in New Haven, CT, Alexion Pharmaceuticals ALXN focuses on the development and commercialization of life-transforming drugs ...
Posted: December 11, 2018, 6:47 am
This blockbuster treatment generates billions in top-line revenue for Alexion Pharmaceuticals(NASDAQ: ALXN), and positive results from a phase 2 study with Ra's lead candidate, zilucoplan, suggest it ...
Posted: December 10, 2018, 12:26 pm
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. RBC Capital analyst Kennen MacKay said Ra Pharmaceuticals (NASDAQ: RARX) Zilucoplan gMG ...
Posted: December 10, 2018, 9:46 am
Alexion Pharmaceuticals (NASDAQ:ALXN) was upgraded by equities researchers at BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Friday. Other analysts also recently issu...
Posted: December 8, 2018, 10:40 pm
Japan-based Chugai Pharmaceutical, which is majority owned by Swiss pharma giant Roche, today announced that it has filed a patent infringement lawsuit at the Tokyo District Court against US drugmaker ...
Posted: December 5, 2018, 6:28 am

Viewing page 1 of 3|Next Page